Delivery Order SPE2DR25D1051-SPE2DR26F39B4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,709.98 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price delivery order, awarded on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a competitively awarded non-set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,301.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement within the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,406.07. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,264.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,113.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,648.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, non-set-aside delivery order was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a purchase order under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,648.51 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract was executed on December 29, 2025, with an ultimate completion date of December 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F39B4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,966.34 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen leverages this comprehensive contract vehicle to supply an extensive range of medications, vaccines, and medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Jardiance order exemplifies the company's role in providing specialty pharmaceutical products across multiple therapeutic domains to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/4/26 |